Morgan Stanley has named Roche, Novartis, and AstraZeneca as their top European pharmaceutical picks for investors. These companies are expected to see strong growth in the coming years, with Roche leading the pack with a projected 16% annual growth rate. Novartis and AstraZeneca are also expected to see solid growth, at 9% and 8% respectively. The pharmaceutical sector is seen as a promising investment opportunity for those looking for steady returns.

Read more at Investing.com: Morgan Stanley’s Top European Pharmaceutical Picks for Investors